Seroprevalence [resa]    
HEPATITIS A [dsyn]    
VIRUSES [virs]    
TURKISH [popg]    
ALCOHOLIC [podg]    
cirrhotics [qlco]    
IMPACT [gngm]    
HEPATITIS B [dsyn]    
Profile [lbpr]    
Introduction [hlca]    
Aims [idcn]    
Study [mnob]    
detect [fndg]    
Seroprevalence [resa]    
HEPATITIS A [dsyn]    
VIRUSES [virs]    
TURKISH [popg]    
ALCOHOLIC [podg]    
cirrhotics [qlco]    
Evaluate [hlca]    
IMPACT [gngm]    
Hepatitis B Infection [dsyn]    
Profile [lbpr]    
methodology [inpr]    
Serological [ftcn]    
Marker [clna]    
HEPATITIS A [dsyn]    
VIRUSES [virs]    
ALCOHOLIC [podg]    
cirrhotics [qlco]    
Diagnosed [fndg]    
January [qlco]    
December [qlco]    
reviewed [inpr]    
Eligible [idcn]    
Patients [podg]    
Divided [ftcn]    
Group 1 [inpr]    
Hb s Ag positive [lbtr]    
Group 2 [inpr]    
Anti Hbc negative [lbtr]    
clinical characteristics [clna]    
Group 1 [inpr]    
Compared [acty]    
Seroprevalence [resa]    
HEPATOCELLULAR CARCINOMA [neop]    
Higher [qlco]    
Hb s Ag positive [lbtr]    
Group [idcn]    
Compared [acty]    
Anti Hbc negative [lbtr]    
Group [idcn]    
clinical Feature [clna]    
Groups [idcn]    
Conclusions [idcn]    
ALCOHOLIC [podg]    
cirrhotics [qlco]    
High frequency [tmco]    
General Population [popg]    
Patients [podg]    
investigated [ftcn]    
HCV [virs]    
Infections [patf]    
VACCINATION [topp]    
neglected [fndg]    
ALCOHOLIC [podg]    
Cirrhotic [qlco]    
Patients [podg]    
Concomitant [tmco]    
screen [hlca]    
HEPATOCELLULAR CARCINOMA [neop]    
